FGF13 antibody (AA 2-18) (FITC)
Quick Overview for FGF13 antibody (AA 2-18) (FITC) (ABIN7540502)
Target
See all FGF13 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 2-18
-
Supplier Product No.
- 200-302-w62
-
Supplier
- Rockland
-
Purpose
- FGFA/FHFA (pan) Antibody Fluorescein
-
Cross-Reactivity (Details)
- BLAST analysis suggests that it is 94 % identical to mouse, 100 % identical to rat and >80 % identical to FGF12A/FHF1A, FGF14A/FHF4A, and FGF11A/FHF3A.
-
Purification
- Anti-FGFA/FHFA (pan) Antibody was purified from concentrated tissue culture supernate by Protein G chromatography.
-
Sterility
- Sterile filtered
-
Immunogen
- Anti-FGFA/FHFA (pan) Antibody was produced by repeated immunization of mice with a synthetic peptide containing amino acids 2-18 of human FHF2A.
-
Isotype
- IgG2b
-
-
-
-
Application Notes
-
ELISA_Dilution: 1:10,000
Immunohistochemistry_Dilution: User Optimized
Western_Blot_Dilution: 1:1000
-
Comment
-
Anti-FGFA/FHFA (pan) FITC Conjugated Antibody is tested for Western Blots, Immunohistochemistry and Immunocytochemistry. Expect a band approximately ~30 kDa on specific lysates or tissues. Does not cross react with FGF13B/FHF2B. Will cross react with FGF12A/FHF1A and FGF14A/FHF4A. Specific conditions for reactivity should be optimized by the end user.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
Stabilizer: 50 % (v/v) Glycerol
Preservative: 0.1 % (w/v) Sodium Azide -
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.
-
Expiry Date
- 12 months
-
-
- FGF13 (Fibroblast Growth Factor 13 (FGF13))
-
Alternative Name
- FGF13
-
Background
- Acidic fibroblast growth factor, AFGF, Beta endothelial cell growth factor, Fibroblast growth factor homologous factor 2A, Fibroblast growth factor 13A, FGF13A, Beta-endothelial cell growth factor, ECGF, ECGFA antibody, ECGFB, FHF-2, FHF2, FHF13, Fibroblast growth factor homologous factor 2, Fibroblast growth factor 13,FGF13(Fibroblast growth factor 13), also called FHF2 is a protein that in humans is encoded by the FGF13 gene. The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF13is a large gene, extending over approximately 200 kb in Xq26.3, and contains at least 7 exons. By cytogenetic, FISH, and database analysis, Gecz et al. (1999) localized the FGF13 gene within a 400-kb duplication interval on chromosome Xq26.3. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth, and invasion. Other areas of interests and use for researchers include cancer, borjeson-forssman-lehmann syndrome, regulation of actin cytoskeleton pathways, apoptosis, GPCR pathways, TGF-Beta pathways, and Rho family GTPase pathways. This gene is located to a region associated with Borjeson-Forssman-Lehmann syndrome (BFLS), a syndromal X-linked mental retardation, which suggests it may be a candidate gene for familial cases of the BFL syndrome. The function of this gene has not yet been determined. Two alternatively spliced transcripts encoding different isoforms have been described for this gene.
-
Gene ID
- 2258
-
UniProt
- Q92913
-
Pathways
- Regulation of Cell Size
Target
-